Method for predicting the responsiveness a patient to a treatment with an anti-CD20 antibody
Abstract:
The present invention relates to a method for predicting the responsiveness of a patient to a treatment with an anti-CD20 antibody, said method comprising measuring the level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in B cells obtained from said patient.
Information query
Patent Agency Ranking
0/0